EPAS1 and liver cancer: More recently it was reported that SerpinB3 (SB3), a hypoxia and HIF-2α-dependent cysteine-protease inhibitor, can directly neddylate and stabilise HIF-2α, which led to an upregulation of its target genes in liver cancer cells [123].